BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33559936)

  • 1. Circ-Zfp644 acts as a pro-hypertrophic mediator in an Ang-II induced in vitro myocardial hypertrophy model.
    Chen Y; Song D; Gao J; Zhang X; Chen X
    Cell Biol Int; 2021 Jun; 45(6):1260-1268. PubMed ID: 33559936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.
    Long Y; Wang L; Li Z
    J Cell Mol Med; 2020 Jul; 24(13):7115-7126. PubMed ID: 32436661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
    Zuo H; Li L; Wang X; Chen S; Liao Z; Wei S; Ruan H; Li T; Chen J
    Hypertens Res; 2023 Feb; 46(2):421-436. PubMed ID: 36474029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
    Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
    Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting role of circ-Jarid2/miR-129-5p/Celf1 axis in cardiac hypertrophy.
    Fang Y; Tao Y; Zhou H; Lai H
    Gene Ther; 2021 Dec; 28(12):718-728. PubMed ID: 32632266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
    Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
    Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0001052 promotes cardiac hypertrophy via elevating Hipk3.
    Yang M; Wang W; Wang L; Li Y
    Aging (Albany NY); 2023 Feb; 15(4):1025-1038. PubMed ID: 36800233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA Larp4b/miR-298-5p/Mef2c Regulates Cardiac Hypertrophy Induced by Angiotensin II.
    Xie Q; Xu X; Xiong D; Yao M; Zhou Y
    Int J Sports Med; 2024 Jan; 45(1):33-40. PubMed ID: 37956874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.
    Pan J; Xu Z; Guo G; Xu C; Song Z; Li K; Zhong K; Wang D
    Bioengineered; 2021 Dec; 12(1):5373-5385. PubMed ID: 34468254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_ZFP644 attenuates caerulein-induced inflammatory injury in rat pancreatic acinar cells by modulating miR-106b/Pias3 axis.
    Wang J; Fu J; Xu C; Jia R; Zhang X; Zhao S
    Exp Mol Pathol; 2021 Aug; 121():104644. PubMed ID: 33945806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of SNHG16 induced by CTCF accelerates cardiac hypertrophy by targeting miR-182-5p/IGF1 axis.
    Wang D; Lin B; Zhang W; Wang X
    Cell Biol Int; 2020 Jul; 44(7):1426-1435. PubMed ID: 32125046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
    Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
    Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0012673 facilitates lung cancer cell proliferation and invasion via miR-320a/LIMK18521 axis.
    Qin H; Liu J; Du ZH; Hu R; Yu YK; Wang QA
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1841-1852. PubMed ID: 32141553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
    Lu Y; Wu F
    Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1).
    Ding Y; Wang J; Lu J
    Bioengineered; 2021 Dec; 12(1):6771-6781. PubMed ID: 34515612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy.
    Wang Y; Cao R; Yang W; Qi B
    J Cell Physiol; 2019 Aug; 234(8):14319-14329. PubMed ID: 30652310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y mediates cardiac hypertrophy through microRNA-216b/FoxO4 signaling pathway.
    Wang J; Hao D; Zeng L; Zhang Q; Huang W
    Int J Med Sci; 2021; 18(1):18-28. PubMed ID: 33390770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
    Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
    Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy.
    Wang W; Wang L; Yang M; Wu C; Lan R; Wang W; Li Y
    Cell Death Dis; 2021 Nov; 12(11):1069. PubMed ID: 34759275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.